DK100888A - Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer - Google Patents

Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer

Info

Publication number
DK100888A
DK100888A DK100888A DK100888A DK100888A DK 100888 A DK100888 A DK 100888A DK 100888 A DK100888 A DK 100888A DK 100888 A DK100888 A DK 100888A DK 100888 A DK100888 A DK 100888A
Authority
DK
Denmark
Prior art keywords
antigen
hepatitis
yes
clean
procedure
Prior art date
Application number
DK100888A
Other languages
English (en)
Other versions
DK100888D0 (da
Inventor
Shigeko Yamazaki
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK100888D0 publication Critical patent/DK100888D0/da
Publication of DK100888A publication Critical patent/DK100888A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK100888A 1987-02-27 1988-02-26 Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer DK100888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1982087A 1987-02-27 1987-02-27

Publications (2)

Publication Number Publication Date
DK100888D0 DK100888D0 (da) 1988-02-26
DK100888A true DK100888A (da) 1988-10-28

Family

ID=21795203

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100888A DK100888A (da) 1987-02-27 1988-02-26 Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer

Country Status (5)

Country Link
EP (1) EP0280470B1 (da)
JP (1) JPS63270628A (da)
AT (1) ATE91304T1 (da)
DE (1) DE3882154T2 (da)
DK (1) DK100888A (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE93891T1 (de) * 1987-03-09 1993-09-15 Merck & Co Inc Reinigung von rekombiniertem hepatitis-boberfl|chen-antigen.
EP0314240A3 (en) * 1987-10-26 1990-03-28 Merck & Co. Inc. Process for purifying recombinant hepatitis antigens
US5011915A (en) * 1987-10-26 1991-04-30 Merck & Co., Inc. Process for purifying recombinant hepatitis antigens
JPH0216975A (ja) * 1988-02-09 1990-01-19 Eugene Tech Internatl Inc 異成分混交性のプレーsに富んだb型肝炎表面抗原
IL99025A0 (en) * 1990-08-15 1992-07-15 Astra Ab Novel process for the detection of pathogens using dna probes
CU22290A1 (es) * 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (da) * 1981-08-04 1984-08-04 Univ California
EP0135435A3 (en) * 1983-08-22 1987-03-25 Merck & Co. Inc. Immunogenic hbsag derived from transformed yeast
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
EP0232410A4 (en) * 1985-08-15 1988-01-25 Amgen CLEAVAGE PROCESS AND BUFFER FOR THE EXTRACTION OF HEPATITIS B SURFACE ANTIGENS FROM YEAR CELLS.
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
JPS63270628A (ja) 1988-11-08
EP0280470B1 (en) 1993-07-07
DE3882154D1 (de) 1993-08-12
DK100888D0 (da) 1988-02-26
EP0280470A1 (en) 1988-08-31
DE3882154T2 (de) 1993-12-02
ATE91304T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
NO893149L (no) Fremgangsmaate til mikrobiologisk fremstilling av humant serumalbumin og andre heterologe proteiner fra gjaer.
DE69333802D1 (de) Äusseres membranprotein von haemophilus
DK0732340T3 (da) Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle
DK0754704T3 (da) Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus
DE69535601D1 (de) Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE3773963D1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
DK110190A (da) Alveolaere surfaktantproteiner
DK100888D0 (da) Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
FI943626A (fi) Rekombinanttiadenovirusrokotteita
ES2075068T3 (es) Procedimiento de preparacion de una proteina mediante levaduras que utiliza un sistema inducible, vectores y cepas transformadas correspondientes.
AU5398898A (en) Recombinant fusion proteins of the porcine reproductive and respiratory syndrome virus (PRRSV) and its use in diagnosis
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
DK0454739T3 (da) Fremgangsmåde til isolering af oprenset EPI protein fra en opløsning, især en fermenteringsopløsning
DK447784D0 (da) Immuninterferon
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
DE3861648D1 (de) Modifizierte anorganische filtermembran zur proteintrennung.
ATE60247T1 (de) Modifizierte anorganische filtermembran zur proteintrennung.
DE3784891D1 (de) Verfahren zur isolierung von saeurestabilen, biologisch aktiven proteinen.
TH22943A (th) รีคอมบิแนนท์โปรตีนที่กำหนดเป็น dev-1 ที่มีประโยชน์สำหรับตรวจหา hiv ลำดับดีเอนเอที่ประมวลรหัสของโปรตีนและการวิเคราะห์ทางอิมมูนโดยใช้โปรตีนนี้
PT89041A (pt) Metodo de preparacao de diagnosticos e vacinas nanbv
KR950025098A (ko) 유전자재조합 곤충세포에서 발현시킨 인간 적혈구성장인자의 정제방법

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment